View in EDS

Adjuvant Trastuzumab Emtansine Versus Paclitaxel Plus Trastuzumab for Stage I Human Epidermal Growth Factor Receptor 2-Positive Breast Cancer: 5-Year Results and Correlative Analyses From ATEMPT.

Saved in:
Bibliographic Details
Title: Adjuvant Trastuzumab Emtansine Versus Paclitaxel Plus Trastuzumab for Stage I Human Epidermal Growth Factor Receptor 2-Positive Breast Cancer: 5-Year Results and Correlative Analyses From ATEMPT.
Authors: Tarantino P; Medical Oncology, Dana-Farber Cancer Institute, Boston, MA.; Breast Oncology Program, Dana-Farber Brigham Cancer Center, Boston, MA.; Harvard Medical School, Boston, MA.; Department of Oncology and Hemato-Oncology, University of Milan, Milan, Italy., Tayob N; Harvard Medical School, Boston, MA.; Division of Data Science, Dana-Farber Cancer Institute, Boston, MA., Villacampa G; SOLTI Breast Cancer Research Group, Barcelona, Spain.; Oncology Data Science Vall d'Hebron Institute of Oncology, Barcelona, Spain., Dang C; Memorial Sloan Kettering Cancer Center, New York, NY., Yardley DA; Sarah Cannon Research Institute and Tennessee Oncology, Nashville, TN., Isakoff SJ; Harvard Medical School, Boston, MA.; Massachusetts General Hospital, Boston, MA., Valero V; MD Anderson Cancer Center, Houston, TX., Faggen M; Medical Oncology, Dana-Farber Cancer Institute, Boston, MA., Mulvey T; Harvard Medical School, Boston, MA.; Massachusetts General Hospital, Boston, MA., Bose R; Washington University School of Medicine, St Louis, MO., Weckstein D; New Hampshire Oncology Hematology, Manchester, NH., Wolff AC; Johns Hopkins Sidney Kimmel Cancer Center, Washington, DC., Reeder-Hayes K; University of North Carolina Lineberger Comprehensive Cancer Center, Chapel Hill, NC., Rugo HS; University of California, San Francisco, CA., Ramaswamy B; Ohio State University Comprehensive Cancer Center, Columbus, OH., Zuckerman D; St Luke's Mountain States Tumor Institute, Boise, ID., Hart L; Wake Forest Baptist Health, Winston-Salem, NC., Gadi VK; University of Illinois Cancer Center, Chicago, IL., Constantine M; Medical Oncology, Dana-Farber Cancer Institute, Boston, MA., Cheng K; North Shore-LIJ Cancer Institute, Lake Success, NY., Garrett AM; Northern Light Cancer Care, Brewer, ME., Marcom PK; Duke University School of Medicine, Durham, NC., Albain K; Loyola University Medical Center, Maywood, IL., DeFusco P; Hartford Healthcare Cancer Institute, Hartford, CT., Tung N; Harvard Medical School, Boston, MA.; Beth Israel Deaconess Medical Center, Boston, MA., Ardman B; Lowell General Hospital, Lowell, MA., Nanda R; UChicago Medicine, Chicago, IL., Jankowitz RC; Perelman Center for Advanced Medicine, Philadelphia, PA., Rimawi M; Dan L. Duncan Comprehensive Cancer Center, Baylor College of Medicine, Houston, TX., Abramson V; Vanderbilt-Ingram Cancer Center, Nashville, TN., Pohlmann PR; MD Anderson Cancer Center, Houston, TX.; Lombardi Comprehensive Cancer Center, Georgetown University Medical Center, Washington, DC., Van Poznak C; Rogel Cancer Center, University of Michigan, Ann Arbor, MI., Forero-Torres A; Kirklin UAB Hematology Oncology, Birmingham, AL., Liu MC; Natera, Inc, Austin, TX., Ruddy KJ; Mayo Clinic, Rochester, NY., Waks AG; Medical Oncology, Dana-Farber Cancer Institute, Boston, MA.; Breast Oncology Program, Dana-Farber Brigham Cancer Center, Boston, MA.; Harvard Medical School, Boston, MA., DeMeo M; Breast Oncology Program, Dana-Farber Brigham Cancer Center, Boston, MA., Burstein HJ; Medical Oncology, Dana-Farber Cancer Institute, Boston, MA.; Breast Oncology Program, Dana-Farber Brigham Cancer Center, Boston, MA.; Harvard Medical School, Boston, MA., Partridge AH; Medical Oncology, Dana-Farber Cancer Institute, Boston, MA.; Breast Oncology Program, Dana-Farber Brigham Cancer Center, Boston, MA.; Harvard Medical School, Boston, MA., Dell'Orto P; IEO European Institute of Oncology, IRCCS, Milan, Italy., Russo L; IEO European Institute of Oncology, IRCCS, Milan, Italy., Krause E; PathAI, Boston, MA., Newhouse DJ; NanoString Technologies, Inc, Boston, MA., Kurt BB; Breast Oncology Program, Dana-Farber Brigham Cancer Center, Boston, MA., Mittendorf EA; Breast Oncology Program, Dana-Farber Brigham Cancer Center, Boston, MA.; Harvard Medical School, Boston, MA.; Division of Breast Surgery, Department of Surgery, Brigham and Women's Hospital, Boston, MA., Schneider B; Indiana University School of Medicine, Indianapolis, IN., Prat A; SOLTI Breast Cancer Research Group, Barcelona, Spain.; Translational Genomics and Targeted Therapeutics in Solid Tumors, August Pi i Sunyer Biomedical Research Institute (IDIBAPS), Barcelona, Spain.; Department of Medical Oncology, Hospital Clinic of Barcelona, Barcelona, Spain., Winer EP; Medical Oncology, Dana-Farber Cancer Institute, Boston, MA.; Breast Oncology Program, Dana-Farber Brigham Cancer Center, Boston, MA.; Harvard Medical School, Boston, MA.; Yale Cancer Center, New Haven, CT., Krop IE; Medical Oncology, Dana-Farber Cancer Institute, Boston, MA.; Breast Oncology Program, Dana-Farber Brigham Cancer Center, Boston, MA.; Harvard Medical School, Boston, MA.; Yale Cancer Center, New Haven, CT., Tolaney SM; Medical Oncology, Dana-Farber Cancer Institute, Boston, MA.; Breast Oncology Program, Dana-Farber Brigham Cancer Center, Boston, MA.; Harvard Medical School, Boston, MA.
Corporate Authors: Consortium of the TBCRC Translational Investigators, TBCRC Translational Investigators
Source: Journal of clinical oncology : official journal of the American Society of Clinical Oncology [J Clin Oncol] 2024 Nov; Vol. 42 (31), pp. 3652-3665. Date of Electronic Publication: 2024 Jun 27.
Publication Type: Journal Article; Randomized Controlled Trial; Clinical Trial, Phase II; Multicenter Study; Comparative Study
Journal Info: Publisher: American Society of Clinical Oncology Country of Publication: United States NLM ID: 8309333 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1527-7755 (Electronic) Linking ISSN: 0732183X NLM ISO Abbreviation: J Clin Oncol Subsets: MEDLINE
Database: MEDLINE Ultimate
FullText Text:
  Availability: 0
Header DbId: mdl
DbLabel: MEDLINE Ultimate
An: 38935923
AccessLevel: 2
PubType: Academic Journal
PubTypeId: academicJournal
PreciseRelevancyScore: 0
IllustrationInfo
Items – Name: Title
  Label: Title
  Group: Ti
  Data: Adjuvant Trastuzumab Emtansine Versus Paclitaxel Plus Trastuzumab for Stage I Human Epidermal Growth Factor Receptor 2-Positive Breast Cancer: 5-Year Results and Correlative Analyses From ATEMPT.
– Name: Author
  Label: Authors
  Group: Au
  Data: <searchLink fieldCode="AU" term="%22Tarantino+P%22">Tarantino P</searchLink>; Medical Oncology, Dana-Farber Cancer Institute, Boston, MA.; Breast Oncology Program, Dana-Farber Brigham Cancer Center, Boston, MA.; Harvard Medical School, Boston, MA.; Department of Oncology and Hemato-Oncology, University of Milan, Milan, Italy.<br /><searchLink fieldCode="AU" term="%22Tayob+N%22">Tayob N</searchLink>; Harvard Medical School, Boston, MA.; Division of Data Science, Dana-Farber Cancer Institute, Boston, MA.<br /><searchLink fieldCode="AU" term="%22Villacampa+G%22">Villacampa G</searchLink>; SOLTI Breast Cancer Research Group, Barcelona, Spain.; Oncology Data Science Vall d'Hebron Institute of Oncology, Barcelona, Spain.<br /><searchLink fieldCode="AU" term="%22Dang+C%22">Dang C</searchLink>; Memorial Sloan Kettering Cancer Center, New York, NY.<br /><searchLink fieldCode="AU" term="%22Yardley+DA%22">Yardley DA</searchLink>; Sarah Cannon Research Institute and Tennessee Oncology, Nashville, TN.<br /><searchLink fieldCode="AU" term="%22Isakoff+SJ%22">Isakoff SJ</searchLink>; Harvard Medical School, Boston, MA.; Massachusetts General Hospital, Boston, MA.<br /><searchLink fieldCode="AU" term="%22Valero+V%22">Valero V</searchLink>; MD Anderson Cancer Center, Houston, TX.<br /><searchLink fieldCode="AU" term="%22Faggen+M%22">Faggen M</searchLink>; Medical Oncology, Dana-Farber Cancer Institute, Boston, MA.<br /><searchLink fieldCode="AU" term="%22Mulvey+T%22">Mulvey T</searchLink>; Harvard Medical School, Boston, MA.; Massachusetts General Hospital, Boston, MA.<br /><searchLink fieldCode="AU" term="%22Bose+R%22">Bose R</searchLink>; Washington University School of Medicine, St Louis, MO.<br /><searchLink fieldCode="AU" term="%22Weckstein+D%22">Weckstein D</searchLink>; New Hampshire Oncology Hematology, Manchester, NH.<br /><searchLink fieldCode="AU" term="%22Wolff+AC%22">Wolff AC</searchLink>; Johns Hopkins Sidney Kimmel Cancer Center, Washington, DC.<br /><searchLink fieldCode="AU" term="%22Reeder-Hayes+K%22">Reeder-Hayes K</searchLink>; University of North Carolina Lineberger Comprehensive Cancer Center, Chapel Hill, NC.<br /><searchLink fieldCode="AU" term="%22Rugo+HS%22">Rugo HS</searchLink>; University of California, San Francisco, CA.<br /><searchLink fieldCode="AU" term="%22Ramaswamy+B%22">Ramaswamy B</searchLink>; Ohio State University Comprehensive Cancer Center, Columbus, OH.<br /><searchLink fieldCode="AU" term="%22Zuckerman+D%22">Zuckerman D</searchLink>; St Luke's Mountain States Tumor Institute, Boise, ID.<br /><searchLink fieldCode="AU" term="%22Hart+L%22">Hart L</searchLink>; Wake Forest Baptist Health, Winston-Salem, NC.<br /><searchLink fieldCode="AU" term="%22Gadi+VK%22">Gadi VK</searchLink>; University of Illinois Cancer Center, Chicago, IL.<br /><searchLink fieldCode="AU" term="%22Constantine+M%22">Constantine M</searchLink>; Medical Oncology, Dana-Farber Cancer Institute, Boston, MA.<br /><searchLink fieldCode="AU" term="%22Cheng+K%22">Cheng K</searchLink>; North Shore-LIJ Cancer Institute, Lake Success, NY.<br /><searchLink fieldCode="AU" term="%22Garrett+AM%22">Garrett AM</searchLink>; Northern Light Cancer Care, Brewer, ME.<br /><searchLink fieldCode="AU" term="%22Marcom+PK%22">Marcom PK</searchLink>; Duke University School of Medicine, Durham, NC.<br /><searchLink fieldCode="AU" term="%22Albain+K%22">Albain K</searchLink>; Loyola University Medical Center, Maywood, IL.<br /><searchLink fieldCode="AU" term="%22DeFusco+P%22">DeFusco P</searchLink>; Hartford Healthcare Cancer Institute, Hartford, CT.<br /><searchLink fieldCode="AU" term="%22Tung+N%22">Tung N</searchLink>; Harvard Medical School, Boston, MA.; Beth Israel Deaconess Medical Center, Boston, MA.<br /><searchLink fieldCode="AU" term="%22Ardman+B%22">Ardman B</searchLink>; Lowell General Hospital, Lowell, MA.<br /><searchLink fieldCode="AU" term="%22Nanda+R%22">Nanda R</searchLink>; UChicago Medicine, Chicago, IL.<br /><searchLink fieldCode="AU" term="%22Jankowitz+RC%22">Jankowitz RC</searchLink>; Perelman Center for Advanced Medicine, Philadelphia, PA.<br /><searchLink fieldCode="AU" term="%22Rimawi+M%22">Rimawi M</searchLink>; Dan L. Duncan Comprehensive Cancer Center, Baylor College of Medicine, Houston, TX.<br /><searchLink fieldCode="AU" term="%22Abramson+V%22">Abramson V</searchLink>; Vanderbilt-Ingram Cancer Center, Nashville, TN.<br /><searchLink fieldCode="AU" term="%22Pohlmann+PR%22">Pohlmann PR</searchLink>; MD Anderson Cancer Center, Houston, TX.; Lombardi Comprehensive Cancer Center, Georgetown University Medical Center, Washington, DC.<br /><searchLink fieldCode="AU" term="%22Van+Poznak+C%22">Van Poznak C</searchLink>; Rogel Cancer Center, University of Michigan, Ann Arbor, MI.<br /><searchLink fieldCode="AU" term="%22Forero-Torres+A%22">Forero-Torres A</searchLink>; Kirklin UAB Hematology Oncology, Birmingham, AL.<br /><searchLink fieldCode="AU" term="%22Liu+MC%22">Liu MC</searchLink>; Natera, Inc, Austin, TX.<br /><searchLink fieldCode="AU" term="%22Ruddy+KJ%22">Ruddy KJ</searchLink>; Mayo Clinic, Rochester, NY.<br /><searchLink fieldCode="AU" term="%22Waks+AG%22">Waks AG</searchLink>; Medical Oncology, Dana-Farber Cancer Institute, Boston, MA.; Breast Oncology Program, Dana-Farber Brigham Cancer Center, Boston, MA.; Harvard Medical School, Boston, MA.<br /><searchLink fieldCode="AU" term="%22DeMeo+M%22">DeMeo M</searchLink>; Breast Oncology Program, Dana-Farber Brigham Cancer Center, Boston, MA.<br /><searchLink fieldCode="AU" term="%22Burstein+HJ%22">Burstein HJ</searchLink>; Medical Oncology, Dana-Farber Cancer Institute, Boston, MA.; Breast Oncology Program, Dana-Farber Brigham Cancer Center, Boston, MA.; Harvard Medical School, Boston, MA.<br /><searchLink fieldCode="AU" term="%22Partridge+AH%22">Partridge AH</searchLink>; Medical Oncology, Dana-Farber Cancer Institute, Boston, MA.; Breast Oncology Program, Dana-Farber Brigham Cancer Center, Boston, MA.; Harvard Medical School, Boston, MA.<br /><searchLink fieldCode="AU" term="%22Dell'Orto+P%22">Dell'Orto P</searchLink>; IEO European Institute of Oncology, IRCCS, Milan, Italy.<br /><searchLink fieldCode="AU" term="%22Russo+L%22">Russo L</searchLink>; IEO European Institute of Oncology, IRCCS, Milan, Italy.<br /><searchLink fieldCode="AU" term="%22Krause+E%22">Krause E</searchLink>; PathAI, Boston, MA.<br /><searchLink fieldCode="AU" term="%22Newhouse+DJ%22">Newhouse DJ</searchLink>; NanoString Technologies, Inc, Boston, MA.<br /><searchLink fieldCode="AU" term="%22Kurt+BB%22">Kurt BB</searchLink>; Breast Oncology Program, Dana-Farber Brigham Cancer Center, Boston, MA.<br /><searchLink fieldCode="AU" term="%22Mittendorf+EA%22">Mittendorf EA</searchLink>; Breast Oncology Program, Dana-Farber Brigham Cancer Center, Boston, MA.; Harvard Medical School, Boston, MA.; Division of Breast Surgery, Department of Surgery, Brigham and Women's Hospital, Boston, MA.<br /><searchLink fieldCode="AU" term="%22Schneider+B%22">Schneider B</searchLink>; Indiana University School of Medicine, Indianapolis, IN.<br /><searchLink fieldCode="AU" term="%22Prat+A%22">Prat A</searchLink>; SOLTI Breast Cancer Research Group, Barcelona, Spain.; Translational Genomics and Targeted Therapeutics in Solid Tumors, August Pi i Sunyer Biomedical Research Institute (IDIBAPS), Barcelona, Spain.; Department of Medical Oncology, Hospital Clinic of Barcelona, Barcelona, Spain.<br /><searchLink fieldCode="AU" term="%22Winer+EP%22">Winer EP</searchLink>; Medical Oncology, Dana-Farber Cancer Institute, Boston, MA.; Breast Oncology Program, Dana-Farber Brigham Cancer Center, Boston, MA.; Harvard Medical School, Boston, MA.; Yale Cancer Center, New Haven, CT.<br /><searchLink fieldCode="AU" term="%22Krop+IE%22">Krop IE</searchLink>; Medical Oncology, Dana-Farber Cancer Institute, Boston, MA.; Breast Oncology Program, Dana-Farber Brigham Cancer Center, Boston, MA.; Harvard Medical School, Boston, MA.; Yale Cancer Center, New Haven, CT.<br /><searchLink fieldCode="AU" term="%22Tolaney+SM%22">Tolaney SM</searchLink>; Medical Oncology, Dana-Farber Cancer Institute, Boston, MA.; Breast Oncology Program, Dana-Farber Brigham Cancer Center, Boston, MA.; Harvard Medical School, Boston, MA.
– Name: AuthorCorporate
  Label: Corporate Authors
  Group: Au
  Data: <searchLink fieldCode="CA" term="%22Consortium+of+the+TBCRC+Translational+Investigators%22">Consortium of the TBCRC Translational Investigators</searchLink><br /><searchLink fieldCode="CA" term="%22TBCRC+Translational+Investigators%22">TBCRC Translational Investigators</searchLink>
– Name: TitleSource
  Label: Source
  Group: Src
  Data: <searchLink fieldCode="JN" term="%228309333%22">Journal of clinical oncology : official journal of the American Society of Clinical Oncology</searchLink> [J Clin Oncol] 2024 Nov; Vol. 42 (31), pp. 3652-3665. <i>Date of Electronic Publication: </i>2024 Jun 27.
– Name: TypePub
  Label: Publication Type
  Group: TypPub
  Data: Journal Article; Randomized Controlled Trial; Clinical Trial, Phase II; Multicenter Study; Comparative Study
– Name: TitleSource
  Label: Journal Info
  Group: Src
  Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22American+Society+of+Clinical+Oncology%22">American Society of Clinical Oncology </searchLink><i>Country of Publication: </i>United States <i>NLM ID: </i>8309333 <i>Publication Model: </i>Print-Electronic <i>Cited Medium: </i>Internet <i>ISSN: </i>1527-7755 (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%220732183X%22">0732183X </searchLink><i>NLM ISO Abbreviation: </i>J Clin Oncol <i>Subsets: </i>MEDLINE
PLink https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=38935923
RecordInfo BibRecord:
  BibEntity:
    Identifiers:
      – Type: doi
        Value: 10.1200/JCO.23.02170
    Languages:
      – Code: eng
        Text: English
    PhysicalDescription:
      Pagination:
        StartPage: 3652
    Titles:
      – TitleFull: Adjuvant Trastuzumab Emtansine Versus Paclitaxel Plus Trastuzumab for Stage I Human Epidermal Growth Factor Receptor 2-Positive Breast Cancer: 5-Year Results and Correlative Analyses From ATEMPT.
        Type: main
  BibRelationships:
    HasContributorRelationships:
      – PersonEntity:
          Name:
            NameFull: Tarantino P
      – PersonEntity:
          Name:
            NameFull: Tayob N
      – PersonEntity:
          Name:
            NameFull: Villacampa G
      – PersonEntity:
          Name:
            NameFull: Dang C
      – PersonEntity:
          Name:
            NameFull: Yardley DA
      – PersonEntity:
          Name:
            NameFull: Isakoff SJ
      – PersonEntity:
          Name:
            NameFull: Valero V
      – PersonEntity:
          Name:
            NameFull: Faggen M
      – PersonEntity:
          Name:
            NameFull: Mulvey T
      – PersonEntity:
          Name:
            NameFull: Bose R
      – PersonEntity:
          Name:
            NameFull: Weckstein D
      – PersonEntity:
          Name:
            NameFull: Wolff AC
      – PersonEntity:
          Name:
            NameFull: Reeder-Hayes K
      – PersonEntity:
          Name:
            NameFull: Rugo HS
      – PersonEntity:
          Name:
            NameFull: Ramaswamy B
      – PersonEntity:
          Name:
            NameFull: Zuckerman D
      – PersonEntity:
          Name:
            NameFull: Hart L
      – PersonEntity:
          Name:
            NameFull: Gadi VK
      – PersonEntity:
          Name:
            NameFull: Constantine M
      – PersonEntity:
          Name:
            NameFull: Cheng K
      – PersonEntity:
          Name:
            NameFull: Garrett AM
      – PersonEntity:
          Name:
            NameFull: Marcom PK
      – PersonEntity:
          Name:
            NameFull: Albain K
      – PersonEntity:
          Name:
            NameFull: DeFusco P
      – PersonEntity:
          Name:
            NameFull: Tung N
      – PersonEntity:
          Name:
            NameFull: Ardman B
      – PersonEntity:
          Name:
            NameFull: Nanda R
      – PersonEntity:
          Name:
            NameFull: Jankowitz RC
      – PersonEntity:
          Name:
            NameFull: Rimawi M
      – PersonEntity:
          Name:
            NameFull: Abramson V
      – PersonEntity:
          Name:
            NameFull: Pohlmann PR
      – PersonEntity:
          Name:
            NameFull: Van Poznak C
      – PersonEntity:
          Name:
            NameFull: Forero-Torres A
      – PersonEntity:
          Name:
            NameFull: Liu MC
      – PersonEntity:
          Name:
            NameFull: Ruddy KJ
      – PersonEntity:
          Name:
            NameFull: Waks AG
      – PersonEntity:
          Name:
            NameFull: DeMeo M
      – PersonEntity:
          Name:
            NameFull: Burstein HJ
      – PersonEntity:
          Name:
            NameFull: Partridge AH
      – PersonEntity:
          Name:
            NameFull: Dell'Orto P
      – PersonEntity:
          Name:
            NameFull: Russo L
      – PersonEntity:
          Name:
            NameFull: Krause E
      – PersonEntity:
          Name:
            NameFull: Newhouse DJ
      – PersonEntity:
          Name:
            NameFull: Kurt BB
      – PersonEntity:
          Name:
            NameFull: Mittendorf EA
      – PersonEntity:
          Name:
            NameFull: Schneider B
      – PersonEntity:
          Name:
            NameFull: Prat A
      – PersonEntity:
          Name:
            NameFull: Winer EP
      – PersonEntity:
          Name:
            NameFull: Krop IE
      – PersonEntity:
          Name:
            NameFull: Tolaney SM
    IsPartOfRelationships:
      – BibEntity:
          Dates:
            – D: 01
              M: 11
              Text: 2024 Nov
              Type: published
              Y: 2024
          Identifiers:
            – Type: issn-electronic
              Value: 1527-7755
          Numbering:
            – Type: volume
              Value: 42
            – Type: issue
              Value: 31
          Titles:
            – TitleFull: Journal of clinical oncology : official journal of the American Society of Clinical Oncology
              Type: main
ResultId 1